Imperial College London

The company is collaborating with two UK institutes to assess whether its Signatera ctDNA technology can detect disease recurrence in women treated for breast cancer.

A number of these loci were linked to blood pressure medication targets, and the researchers developed a genetic risk score.

By overlaying epilepsy genetic data onto co-expressed gene networks from post-mortem brain samples, researchers proposed a 320-gene expression network for epilepsy.

Using absolute and relative gene expression analyses, researchers identified expression patterns associated with preeclampsia in dozens of placental tissue samples.

Researchers examined virulence, resistance, and transmission patterns in genome sequence data for more than 300 invasive Staphylococcus aureus isolates from Europe.

They will use the funds to develop software tools for designing and testing site-specific CRISPR systems that target drug resistance mechanisms in cancer cells.

Re-sequencing of the Schistosoma mansoni genome provides insight into the parasite's population history.